Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
New to Comunitee?

or Sign Up with Email



APR 24, 2013 - Yahoo! News

A Must Read - Share

Elan sees sales of prized Tysabri drug rise sharply

DUBLIN (Reuters) - Elan said sales of the multiple sclerosis drug Royalty Pharma wants to get its hands on through its bid for the Irish drugmaker rose by 14 percent year-on-year to $456 million in the first quarter. Elan, involved in a convoluted takeover saga with Royalty for the past two months, rejected a reduced $11.25 per share bid from the U.S. investment company on Monday, saying it grossly undervalued its future prospects. ...

Tags: Elan sees sales of prized Tysabri drug rise sharply,  Multiple Sclerosis Latest News